The Mumbai-based drug maker Sun Pharmaceuticals Industries Ltd on August 3 reported a 1.9% YoY decline in its consolidated net profit at Rs 2,022.5 crore
Zydus Lifesciences has received final approval from the USFDA (United States Food and Drug Administration) to manufacture and market its Arthritis drug Indomethacin suppositories 50mg.
Under the futures and options (F&O) segment, four stocks were banned from trade on Wednesday, August 3, by the National Stock Exchange (NSE). The securities
Adani Group of Company-led Ambuja Cement Ltd has announced the acquisition of Sanghi Industries Ltd at an enterprise value of Rs 5,000 crore. The company
Mankind Pharma reported a stellar performance in its quarterly report for the April-June quarter of the current fiscal year. The drugmaker reported a 66.4% increase